4321Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial. (28th August 2018) - Chi, G; Gibson, C M; Hernandez, A F; Hull, R D; Cohen, A T; Harrington, R A; Alkhalfan, F; Kalayci, A; Kerneis, M; Nafee, T; Goldhaber, S Z; ,